1.Meningitis due to Listeria Monocytogenes Following Orthotopic Heart Transplantation.
Jin Il KWON ; Yeong Jun KIM ; Kyung Leem CHOI ; Sang Jin CHOI ; Won Ho JUNG ; Eun A KIM ; Min Soo SHON ; Sae Jin OH ; In Suck CHOI ; Eak Kyun SHIN
Korean Circulation Journal 1998;28(9):1616-1619
We report a first case of meningitis due to listeria monocytogenes after cardiac transplantation in Korea. This patient is a 40-year-old man with Dilated cardiomyopathy, he presented with intermittent dyspnea and abdominal distension for about 1 year. After cardiac transplantation, he was treated with azathioprine, cyclosporine and prednisolone for graft rejection. He was presented with intermittent fever, headache and lethargy for about 10days after cardiac transplantation. Listeria monocytogenes was isolated from blood culture and CSF culture. He was treated with intravenous penicillin G for 10days successfully and changed with ampicillin for 10days, took oral ampicillin for 10days without any complication after discharge.
Adult
;
Ampicillin
;
Azathioprine
;
Cardiomyopathy, Dilated
;
Cyclosporine
;
Dyspnea
;
Fever
;
Graft Rejection
;
Headache
;
Heart Transplantation*
;
Heart*
;
Humans
;
Korea
;
Lethargy
;
Listeria monocytogenes*
;
Listeria*
;
Meningitis*
;
Penicillin G
;
Prednisolone
2.Factors Influencing the Therapeutic Compliance of Patients with Lung Cancer.
Sang Chul CHAE ; Jae Yong PARK ; Jeong Suk KIM ; Moon Seob BAE ; Moo Chul SIN ; Keon Yeob KIM ; Chang Ho KIM ; Sang Kyun SHON ; Sin KAM ; Tae Hoon JUNG
Tuberculosis and Respiratory Diseases 1998;45(5):953-961
BACKGROUND: In recent years, lung cancer has been one of most common cause of death in Korea. Despite many physician's high degree of pessimism about the gains made in treatments progressive improvement in the survival of lung cancer by treatment has occurred, particulary in the early stages of the disease. However, a lot of patients refuse treatment or give up in the fight against the disease. This study was done to evaluate factors ifluencing the compliance to therapy and to lead in the establishment of special programs to enhance compliance in patients with lung cancer. METHODS: The medical records of 903 patients, whose ECOG(Eastern Cooperative Oncology Group) performance status was 3 or less and whose medical record was relatively satisfactory, among 1141 patients diagnosed with lung cancer between January 1989 and December 1996 were reviewed retrospectively. Compliance was classified into three groups based on the degree of compliance with physicians practice guideline : (a) complaints ; (b) patients who initially complied but gave up of themselves midway during the course of treatment ; (c) noncompliants who refused the treatment. RESULTS: The overall compliance rats was 63.9%, which was progressively increased from 57.3-61.3% in 1989 and 1990 to 64.2-67.5% in 1995 and 1996. Age, education level and occupation of patients bore statistically significant relationship with the compliance but sell marital status and smoking history did not. The compliance was significantly higher in patients without symptoms than with, and was also significantly higher in patients with good performance status. The compliance was significantly high in patients with NSCLC(non-small cell lung cancer) compared to SCLC(small cell lung cancer), but after exclusion of stage l and ll, among NSCLC, which had higher compliance to surgery there was no significant difference of compliance by histology. The compliance was significantly lower in advanced stage. CONCLUSION: To enhance the compliance, special care including education programs about therapy including complicantion and prognosis are necessary, especially for educationally and economically disadvantaged patients.
Animals
;
Cause of Death
;
Compliance*
;
Education
;
Humans
;
Korea
;
Lung Neoplasms*
;
Lung*
;
Marital Status
;
Medical Records
;
Occupations
;
Prognosis
;
Rats
;
Retrospective Studies
;
Smoke
;
Smoking
;
Vulnerable Populations
3.A Case of Hepatic Carcinoid Tumor Regression with Octreotide.
Hee Jin CHOI ; Sang Kyun WOO ; Kyung Hee SUH ; Seung Min BAEK ; Hyo Jong BAEK ; Sang Moon LEE ; Won Ho KIM ; Sung Ho KIM ; Ik Su KIM ; Kyung Rak SHON
The Korean Journal of Hepatology 2001;7(1):100-103
Somatostatin analogue octreotide is commonly used for the treatment of carcinoid syndrome. Octreotide also has an antiproliferative effect in neuroendocrine tumors and has demonstrated tumor reduction in patients having advanced carcinoid tumor. This is a case report of a patient who had metastatic liver carcinoid tumor and showed marked regression of liver metastasis after octreotide therapy.
Carcinoid Tumor*
;
Humans
;
Liver
;
Neoplasm Metastasis
;
Neuroendocrine Tumors
;
Octreotide*
;
Somatostatin